Suven Pharmaceuticals
Suven Pharmaceuticals Limited is a bio-pharmaceutical company based in Hyderabad, India, with operations extending to the United States, Europe, and other international markets. Founded in 2018, the company focuses on the development, manufacturing, and sale of new chemical entity intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs. Suven Pharmaceuticals operates primarily through contract research and manufacturing services, catering to the needs of pharmaceutical, biotechnology, and chemical companies. As a subsidiary of Jasti Property and Equity Holdings Private Limited, the company strives to meet customer demands and expectations in the pharmaceutical industry.
Top Stages
2 past transactions
NJ Bio
Acquisition in 2024
NJ Bio is a contract research organization (CRO) and contract development and manufacturing organization (CDMO), specializing in integrated chemistry and biology services for the biotech and pharmaceutical industries. The company offers a range of services, including antibody-drug conjugates, protein production, cell-based assays, and bioanalytical services, aimed at accelerating product development.
Casper Pharma
Acquisition in 2024
Casper Pharma is an emerging specialty pharmaceutical company dedicated to enhancing patients' lives. It focuses on developing, acquiring, and commercializing pharmaceuticals that address medical needs in the cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.